Microenvironmental Interactions and Survival of CLL B-cells

References

• Caligaris-Cappio, F. (2000) "Biology of chronic lymphocytic leukemia", Rev. Clin. Exp. Hematol., 4, 5–21.
   Google Scholar
• Caligaris-Cappio, F. (2003) "Role of the microenvironment in chronic lymphocytic leukaemia", Br. J. Haematol., 123, 380— 388.
   Web of Science ®Google Scholar
• Ghia, P. and Caligaris-Cappio, F. (2000) "The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms", Adv. Cancer Res., 79, 157 — 173.
   Web of Science ®Google Scholar
• Chilosi, M., Pizzolo, G., Caligaris-Cappio, F., Ambrosetti, A., Vinante, F., Morittu, L., et al. (1985) "Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia", Cancer, 56, 328 — 332.
   Web of Science ®Google Scholar
• Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. and Hoflbrand, A.V. (1996) "Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro", Brit. J. Haematol., 92, 97 — 103.
   Web of Science ®Google Scholar
• Lagneawc, L., Delforge, A., Bron, D., De Bruyn, C. and Strychlcmans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood, 91, 2387 — 2396.
   Google Scholar
• Jewell, A.P. and Yong, K.L. (1997) "Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukaemia", Acta Haematol., 97, 67–72.
   PubMed Web of Science ®Google Scholar
• Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell'Aquila, M. and Kipps, T.J. (2000) "Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1", Blood, 96, 2655–2663.
   PubMed Web of Science ®Google Scholar
• Serrano, D., Monteiro, J., Allen, S.L., Kolitz, J., Schulman, P., Lichtman, S.M., et al. (1997) "Clonal expansion within the CD4 + CD57 + and CD8 + CD57 + T cell subsets in chronic lymphocytic leukemia", J. Immunol., 158, 1482— 1489.
   PubMed Web of Science ®Google Scholar
• Pizzolo, G., Chilosi, M., Ambrosetti, A., Semenzato, G., Fiore-Donati, L. and Perona, G. (1983) "Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia", Blood, 62, 1289–1296.
   Google Scholar
• Ghia, P., Granziero, L., Chilosi, M. and Caligaris-Cappio, F. (2002) "Chronic B cell malignancies and bone marrow micro-environment", Semin. Cancer Biol., 12, 149 — 155.
   PubMed Web of Science ®Google Scholar
• Rezvany, MR., Jeddi-Tehrani, M., Osterborg, A., Kimby, E., Wigzell, H. and Mellstedt, H. (1999) "Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset", Blood, 94, 1063— 1069.
   Web of Science ®Google Scholar
• Fluciciger, AC., Rossi, J.F., Bussel, A., Bryon, P., Banchereau, J. and Defrance, T. (1992) "Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors", Blood, 80, 3173–3181.
   PubMed Web of Science ®Google Scholar
• Buske, C., Gogowslci, G., Schreiber, K., Rave-Frank, M., Hiddenmann, W. and Wormann, B. (1997) "Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand", Exp. Hematol., 25, 329 — 337.
   Web of Science ®Google Scholar
• Kitada, S., Zapata, J., Andreeff, M. and Reed, J. (1999) "Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia", Brit. J. Hematol., 106, 995–1004.
   Google Scholar
• Romano, M.F., Lamberti, A., Tassone, P., Alfinito, F., Costantini, S., Chiurazzi, F., et al. (1998) "Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells", Blood, 92, 990–995.
   PubMed Web of Science ®Google Scholar
• Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., et al. (2001) "Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia", Blood, 97, 2777 — 2783.
   Web of Science ®Google Scholar
• Bates, R.C., Lincz, L.F. and Burns, G.F. (1995) "Involvement of integrins in cell survival", Cancer Metastasis Rev., 14, 191–203.
   PubMed Web of Science ®Google Scholar
• Kumar, CC. (1998) "Signaling by integrin receptors", Oncogene, 17, 1365–1373.
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio, F and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukemia: A bird of a different feather", J. Clin. Oncol., 17, 399–408.
   Web of Science ®Google Scholar
• Vincent, A.M., Cawley, J.C. and Burthem, J. (1996) "Integrin function in chronic lymphocytic leukemia", Blood, 87, 4780–4788.
   Google Scholar
• Takeuchi, H. and Katayama, I. (1993) "Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias", Leuk. Lymphoma, 10, 209–216.
   PubMed Web of Science ®Google Scholar
• Bannerji, R. and Byrd, J.C. (2000) "Update on the biology of chronic lymphocytic leukemia", Curr. Opin. Oncol., 12, 22–29.
   PubMed Web of Science ®Google Scholar
• de la Fuente, MT., Casanova, B., Garcia-Gila, M., Silva, A. and Garcia-Pardo, A. (1999) "Fibronectin interaction with alpha4be-ta 1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bc1-2 and Bax", Leukemia, 13, 266 — 274.
   Web of Science ®Google Scholar
• Plate, J.M., Long, B.W. and Kelkar, S.B. (2000) "Role of beta2 integrins in the prevention of apoptosis induction in chronic lymphocytic leukemia B cells", Leukemia, 14, 34— 39.
   Web of Science ®Google Scholar
• de la Fuente, MT., Casanova, B., Moyano, J.V., Garcia-Gila, M., Sanz, L., Garcia-Marco, J., et al. (2002) "Engagement of alpha4beta 1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine", J. Leukoc. Biol., 71, 495–502.
   PubMed Web of Science ®Google Scholar
• Naor, D., Nedvetzlci, S., Golan, I., Melnik, L. and Faitelson, Y. (2002) "CD44 in cancer", Crit. Rev. Clin. Lab. Sci., 39, 527–579.
   Google Scholar
• Eistere, W., Hilbe, W., Stauder, R., Bechter, 0., Fend, F. and Thaler, J. (1996) "An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD1 lc", Br. J. Haematol., 93, 661–669.
   PubMed Web of Science ®Google Scholar
• Matutes, E. and Polliack, A. (2000) "Morphological and im-munophenotypic features of chronic lymphocytic leukemia", Rev. Clin. Exp. Hematol., 4, 22–47.
   Google Scholar
• Cambier, J.C. (1995) "Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM)", J. Immunol., 155, 3281–3285.
   PubMed Web of Science ®Google Scholar
• Zomas, A.P., Matutes, E., Morilla, R., Owusu-Ankomah, K., Seon, B.K. and Catovsky, D. (1996) "Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)", Leukemia, 10, 1966 — 1970.
   Google Scholar
• Alfarano, A., Indraccolo, S., Circosta, P., Minuzzo, S., Vallario, A., Zamarchi, R., et al. (1999) "An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia", Blood, 93, 2327 — 2335.
   Google Scholar
• Hashimoto, S., Chiorazzi, N. and Gregersen, P.K. (1995) "Alter-native splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/ B29) RNA transcripts in human B cells", Mol. Immunol., 32, 651 — 659.
   Web of Science ®Google Scholar
• Cragg, M.S., Chan, H.T., Fox, M.D., Tutt, A., Smith, A., Oscier, D.G., et al. (2002) "The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis", Blood, 100, 3068 — 3076.
   Web of Science ®Google Scholar
• Hamblin, T.J., Davis, Z., Gardner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood, 94, 1848— 1854.
   Web of Science ®Google Scholar
• Damle, RN., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., et al. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood, 94, 1840— 1847.
   Web of Science ®Google Scholar
• Zupo, S., Isnardi, L., Megna, M., Massara, R., Malavasi, F., Dono, M., et al. (1996) "CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis", Blood, 88, 1365— 1374.
   Google Scholar
• Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, KR., Weiss, A., et al. (2002) "Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia", Blood, 100, 4609–4614.
   PubMed Web of Science ®Google Scholar
• Rasenti, L., Huynh, L., Toy, T.L., Chen, L., et al. (2004) "Zap-70 is a stronger predictor of early disease-progression risk than immunoglobulin mutation status in chronic lymphocytic leuke-mia", N. Eng. J. Med., in press.
   Google Scholar
• Chen, L., Dicker, F., Apgar, J., Giago-McGaham, T., et al. (2003) "Demonstration that ZAP-70 directly contributes to enhanced B-cell receptor signaling in chronic lymphocytic leukemia cells", Blood, 102, 107a.
   Google Scholar
• Zupo, S., Massara, R., Dono, M., Rossi, E., Malavasi, F., Cosulich, ME., et al. (2000) "Apoptosis or plasma cell differentia-tion of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD", Blood, 95, 1199 — 1206.
   Google Scholar
• Chiorazzi, N. and Ferrarini, M. (2003) "B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor", Annu. Rev. Immunol., 21, 841–894.
   Google Scholar
• Mackay, F. and Ambrose, C. (2003) "The TNF family members BAFF and APRIL: the growing complexity", Cytokine Growth Factor Rev., 14, 311–324.
   PubMed Web of Science ®Google Scholar
• Grewal, IS. and Flavell, R.A. (1998) "CD40 and CD154 in cell-mediated immunity", Annu. Rev. Immunol., 16, 111 —135.
   Google Scholar
• Vogel, L.A. and Noelle, R.J. (1998) "CD40 and its crucial role as a member of the TNFR family", Semin. Immunol., 10, 435–442.
   Web of Science ®Google Scholar
• Trentin, L., Zambello, R., Sancetta, R., Facco, M., Cerutti, A., Perin, A., et al. (1997) "B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimu-latory molecules", Cancer Res., 57, 4940–4947.
   PubMed Web of Science ®Google Scholar
• Wierda, W.G., Cantwell, Mi., Woods, S.J., Rassenti, L.Z., Prussak, C.E. and Kipps, T.J. (2000) "CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia", Blood, 96, 2917 — 2924.
   Google Scholar
• Anether, G., Marschitz, I., Tinhofer, I. and Greil, R. (2002) "Interleulcin-15 as a potential costimulatory cytolcine in CD154 gene therapy of chronic lymphocytic leukemia", Blood, 99, 722 — 723.
   Web of Science ®Google Scholar
• Chu, P., Deforce, D., Pedersen, TM., Kim, Y., Kitada, S., Reed, J.C., et al. (2002) "Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia". Proc. Natl. Acad. Sci. USA, 99, 3854— 3859.
   PubMed Web of Science ®Google Scholar
• Locksley, R.M., Killeen, N. and Lenardo, M.J. (2001) "The TNF and TNF receptor superfamilies: integrating mammalian biology", Cell, 104, 487 — 501.
   Google Scholar
• Gross, J.A., Johnston, J., Mudri, S., Enselman, R., Dillon, SR., Madden, K., et al. (2000) "TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease", Nature, 404, 995–999.
   Google Scholar
• Mackay, F., Woodcock, S.A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., et al. (1999) "Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations", J. Exp. Med., 190, 1697— 1710.
   Web of Science ®Google Scholar
• Do, R.K., Hatada, E., Lee, H., Tourigny, MR., Hilbert, D. and Chen-Kiang, S. (2000) "Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune re-sponse", J. Exp. Med., 192, 953–964.
   PubMed Web of Science ®Google Scholar
• Schneider, P. and Tschopp, J. (2003) "BAFF and the regulation of B cell survival", Immunol. Lett., 88, 57 — 62.
   Google Scholar
• Kern, C., Cornuel, J.F., Billard, C., Tang, R., Rouillard, D., Stenou, V., et al. (2004) "Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway", Blood, 103, 679–688.
   Google Scholar
• Hatada, EN., Do, R.K., Orlofsky, A., Liou, H.C., Prystowsky, M., MacLennan, IC., et al. (2003) "NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells", J. Immunol., 171, 761–768.
   PubMed Web of Science ®Google Scholar
• Kanakaraj, P., Migone, T.S., Nardelli, B., Ullrich, S., Li, Y., Olsen, H.S., et al. (2001) "BLyS binds to b cells with high affinity and induces activation of the transcription factors NF-kappaB and ELF-1", Cytokine, 13, 25 — 31.
   Web of Science ®Google Scholar
• Strasser, A., Harris, A.W., Huang, D.C., Krammer, P.H. and Cory, S. (1995) "Bc1-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis", EMBO J., 14, 6136–6147.
   PubMed Web of Science ®Google Scholar
• Strasser, A., O'Connor, L. and Dixit, V.M. (2000) "Apoptosis signalling", Annu. Rev. Biochem., 69, 217 — 245.
   Google Scholar
• Mak, T.W. and Yeh, W.C. (2002) "Signaling for survival and apoptosis in the immune system", Arthritis Res., 4\(Suppl 3), S243—S252.
   PubMedGoogle Scholar
• Caligaris-Cappio, F. (1996) "B-chronic lymphocytic leukemia: a malignancy of anti-self B cells", Blood, 87, 2615–2620.
   Google Scholar
• Kay, N.E., Hamblin, T.J., Jelinek, D.F., Dewald, G.W., Byrd, J.C., Farag, S., et al. (2002) "Chronic lymphocytic leukemia", Hematology (Am. Soc. HematoL Educ. Program)., 00, 193–213.
   Google Scholar
• Benekli, M., Xia, Z., Donohue, K.A., Ford, L.A., Pixley, L.A., Baer, MR., et al. (2002) "Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival", Blood, 99, 252— 257.
   Web of Science ®Google Scholar
• Tse, K.F., Mukherjee, G. and Small, D. (2000) "Constitutive activation of FLT3 stimulates multiple intracellular signal trans-ducers and results in transformation", Leukemia, 14, 1766 — 1776.
   Web of Science ®Google Scholar
• Milella, M., Kornblau, S.M., Estrov, Z., Carter, B.Z., Lapillonne, H., Harris, D., et al. (2001) "Therapeutic targeting of the MEK/ MAPK signal transduction module in acute myeloid leukemia", J. Clin. Invest., 108, 851–859.
   Google Scholar
• Furman, R.R., Asgary, Z., Mascarebhas, J.0., Liou, H.-C. and Schattner, E.J. (2000) "Modulation of NF-kB activity and apoptosis in chronic lymphocytic leukemia B cells", J. Immunol., 164, 2200–2206.
   PubMed Web of Science ®Google Scholar
• Ringshausen, I., Schneller, F., Bogner, C., Hipp, S., Duyster, J., Peschel, C., et al. (2002) "Constitutively activated phosphatidyli-nosito1-3 lcinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein lcinase Cdelta", Blood, 100, 3741 — 3748.
   Google Scholar
• Barragan, M., Bellosillo, B., Campas, C., Colomer, D., Pons, G. and Gil, J. (2002) "Involvement of protein lcinase C and phosphatidylinositol 3-lcinase pathways in the survival of B-cell chronic lymphocytic leukemia cells", Blood, 99, 2969–2976.
   PubMed Web of Science ®Google Scholar
• Wickremasinghe, R.G., Ganeshaguru, K., Jones, D.T., Lindsay, C., Spanswick, V.J., Hartley, JA., et al. (2001) "Autologous plasma activates Akt/protein lcinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells", Br. J. HaematoL, 114, 608 — 615.
   Web of Science ®Google Scholar
• Frank, D.A., Mahajan, S. and Ritz, J. (1997) "B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues", J. Clin. Invest., 100, 3140–3148.
   Google Scholar
• Epling-Burnette, P.K., Liu, J.H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., et al. (2001) "Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lympho-cytes and decreased Mc-1 expression", J. Clin. Invest., 107, 351 — 362.
   Google Scholar
• Marchisio, M., Grimley, P.M., Di Baldassarre, A., Santavenere, E. and Miscia, S. (2004) "Novel shift of Jak/Stat signalling characterizes the protective effect of aurintricarboxylic acid (ATA) from tumor necrosis factor-alpha toxicity in human B lymphocytes", Int. J. ImmunopathoL Pharmacol., 17, 5–14.
   PubMed Web of Science ®Google Scholar
• Cheng, J.Q., Godwin, AK., Bellacosa, A., Taguchi, T., Franke, T.F., Hamilton, T.C., et al. (1992) "AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine lcinases, is amplified in human ovarian carcinomas", Proc. Natl. Acad. Sci. USA, 89, 9267–9271.
   PubMed Web of Science ®Google Scholar
• Sun, M., Wang, G., Paciga, J.E., Feldman, RI., Yuan, Z.Q., Ma, Xi., et al. (2001) "AKT1/PKBalpha lcinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells", Am. J. PathoL, 159, 431 — 437.
   Web of Science ®Google Scholar
• Zha, J., Harada, H., Yang, E., Jockel, J . and Korsmeyer, (1996) "Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)", Cell, 87, 619 — 628.
   Google Scholar
• Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., et al. "Regulation of cell death protease caspase-9 by phosphorylation", Science, 282, 1318-1321.
   Google Scholar
• Pekarsky, Y., Hallas, C., Palamarchuk, A., Koval, A., Bullrich, F., Hirata, Y., et al. (2001) "Akt phosphorylates and regulates the orphan nuclear receptor Nur77", Proc. Natl. Acad. Sci. USA, 98, 3690— 3694.
   PubMed Web of Science ®Google Scholar
• Li, H., Kolluri, S.K., Gu, J., Dawson, MI., Cao, X., Hobbs, P.D., et al. (2000) "Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3", Science, 289, 1159 — 1164.
   Web of Science ®Google Scholar
• Lin, B., Kolluri, S.K., Lin, F., Liu, W., Han, Y.H., Cao, X., et al. (2004) "Conversion of Bc1-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3", Cell, 116, 527–540.
   Google Scholar
• Masuyama, N., Oishi, K., Mori, Y., Ueno, T., Takahama, Y. and Gotoh, Y. (2001) "Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis", J. Biol. Chem., 276, 32799— 32805.
   Web of Science ®Google Scholar
• Fu, TB., Virgilio, L., Narducci, M.G., Facchiano, A., Russo G. and Croce, C.M. (1994) "Characterization and localization of the TCL-1 oncogene product", Cancer Res., 54, 6297–6301.
   Google Scholar
• Fu, Z.Q., Du Bois, G.C., Song, S.P., Kulikovskaya, I., Virgilio, L., Rothstein, J.L., et al. (1998) "Crystal structure of MTCP-1: implications for role of TCL-1 and MTCP-1 in T cell malig-nancies", Proc. Natl. Acad. Sci. USA, 95, 3413 — 3418.
   PubMed Web of Science ®Google Scholar
• Narducci, M.G., Pescarmona, E., Lazzeri, C., Signoretti, S., Lavinia, A.M., Remotti, D., et al. (2000) "Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues", Cancer Res., 60, 2095–2100.
   PubMed Web of Science ®Google Scholar
• Lu, D., Zhao, Y., Tawatao, R., Cottam, H.B., Sen, M., Leoni, L.M., et al. (2004) "Activation of the Wnt signaling pathway in chronic lymphocytic leukemia",Proc. Natl. Acad. Sci. USA, 101, 3118— 3123.
   PubMed Web of Science ®Google Scholar
• Han, T., Barcos, M., Emrich, L., Ozer, H., Gajera, R., Gomez, G.A., et al. (1984) "Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correla-tions with clinical, immunologic, phenotypic, and cytogenetic data", J. Clin. Oncol., 2, 562— 570.
   Web of Science ®Google Scholar
• Pangalis, GA., Roussou, PA., Kittas, C., Mitsoulis-Mentzikoff, C., Matsouka-Alexandridis, P., Anagnostopoulos, N., et al. (1984) "Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-Hodg-kin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis", Cancer, 54, 702–708.
   PubMed Web of Science ®Google Scholar
• Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. and Stryckmans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood, 91, 2387–2396.
   Google Scholar
• Jurlander, J. (1998) "The cellular biology of B-cell chronic lymphocytic leukemia", Crit. Rew. Oncol. Hematol., 27, 29–52.
   PubMed Web of Science ®Google Scholar
• Granziero, L., Circosta, P., Scielzo, C., Frisaldi, E., Stella, S., Geuna, M., et al. (2003) "CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5 + B lymphocytes", Blood, 101, 1962–1969.
   Web of Science ®Google Scholar
• Nagasawa, T., Kikutani, H. and Kishimoto, T. (1994) "Molecular cloning and structure of a pre-B-cell growth-stimulating factor", Proc. Natl. Acad. Sci. USA, 91, 2305–2309.
   PubMed Web of Science ®Google Scholar
• Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. and Springer, T.A. (1996) "A highly efficacious lymphocyte chemoat-tractant, stromal cell-derived factor 1 (SDF-1)", J. Exp. Med., 184, 1101–1109.
   PubMed Web of Science ®Google Scholar
• Burger, JA., Burger, M. and Kipps, T.J. (1999) "Chronic lymphocytic leukemia B cells express functional CXCR4 chemo-lcine receptors that mediate spontaneous migration beneath bone marrow stromal cells", Blood, 94, 3658–3667.
   PubMed Web of Science ®Google Scholar
• Mohle, R., Failenschmid, C., Bautz, F. and Kanz, L. (1999) "Overexpression of the chemolcine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased func-tional response to stromal cell-derived factor-1 (SDF-1)", Leuke-mia, 13, 1954–1959.
   Web of Science ®Google Scholar
• Lagneaux, L., Delforge, A., Massy, M., Bernier, M., et al. (2000) "Increased production of SDF-1 by bone marrow (BM) stromal cells (SC) derived from chronic lymphocytic leukemia (CLL) patients in comparisons with normal subjects", Blood, 96, 362a.
   Google Scholar
• Wekerle, H., Ketelsen, U.P. and Ernst, M. (1980) "Thymic nurse cells. Lymphoepithelial cell complexes in murine thymuses: morphological and serological characterization", J. Exp. Med., 151, 925–944.
   PubMed Web of Science ®Google Scholar
• Choc, J., Li, L., Zhang, X., Gregory, C.D. and Choi, Y.S. (2000) "Distinct role of follicular dendritic cells and T cells in the proliferation, differentiation, and apoptosis of a centroblast cell line, L3055", J. Immunol., 164, 56–63.
   PubMed Web of Science ®Google Scholar
• Petrasch, S., Brittinger, G., Wacker, H.H., Schmitz, J. and Kosco-Vilbois, M. (1994) "Follicular dendritic cells in non-Hodgkin's lymphomas", Leuk. Lymphoma, 15, 33–43.
   PubMed Web of Science ®Google Scholar
• Pedersen, TM., Kitada, S., Leoni, L.M., Zapata, J.M., Karras, J.G., Tsukada, N., et al. (2002) "Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mc1-1", Blood, 100, 1795 — 1801.
   Google Scholar
• Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewslci, S., et al. (1998) "Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses", Blood, 91, 3379— 3389.
   PubMed Web of Science ®Google Scholar
• Saxena, A., Viswanathan, S., Moshynska, 0., Tandon, P., Sankaran, K. and Sheridan, D.P. (2004) "Mc1-1 and Bc1-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia", Am. J. Hematol., 75, 22–33.
   PubMed Web of Science ®Google Scholar
• Moshynska, 0., Sankaran, K., Pahwa, P. and Saxena, A. (2004) "Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia", J. Natl. Cancer Inst., 6, 673–682.
   PubMed Web of Science ®Google Scholar
• MacFarlane, M., Harper, N., Snowden, R.T., Dyer, Mi., Barnett, G.A., Pringle, J.H., et al. (2002) "Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia", Oncogene, 21, 6809— 6818.
   Google Scholar
• Panayiotidis, P., Ganeshaguru, K., Foroni, L. and Hoffbrand, A.V. (1995) "Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia", Leukemia, 9, 1227–1232.
   Google Scholar
• de Totero, D., Montera, M., Rosso, 0., Clavio, M., Balleari, E., Foa, R., et al. (2004) "Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression", Hematol. J., 5, 152–160.
   PubMedGoogle Scholar